Molecules/TRASTUZUMAB DERUXTECAN

TRASTUZUMAB DERUXTECAN

Molecular Identity

Antibody drug conjugateApprovedFirst approved 2019

Mechanism of action: Receptor protein-tyrosine kinase erbB-2 binding agent

Molecular Formula

0.00

Molecular Weight

g/mol

DS-8201DS-8201aDS-8201AEnhertuFAM-TRASTUZUMAB DERUXTECAN-NXKITRASTUZUMAB DERUXTECANTRASTUZUMAB DERUXTECAN NXKITRASTUZUMAB DERUXTECAN-NXKI

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to TRASTUZUMAB DERUXTECAN

Loading drug network...